It would be opportunistic and yes SI and GG plus others have a combined blocking stake but these big Pharma's need to consider alternative forms of treatment/therapy going forward. Large players could offer a deal that is too good to refuse for the PLATFORM. The mechanism. GHVD is only one indication. The platform could deal with so many other medical issues around prolific inflammation/cytokine storm to promote healing and survival especially for unmet needs. I guess money talks and we will have to wait and see....
It would be opportunistic and yes SI and GG plus others have a...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
0.075(6.91%) |
Mkt cap ! $1.324B | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.20 | $1.11 | $13.22M | 11.34M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 79841 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 3486 | 1 |
View Market Depth
| Last trade - 14.02pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.17 |
Change
0.075 ( 7.93 %) |
||||
| Open | High | Low | Volume | ||
| $1.12 | $1.20 | $1.12 | 2643628 | ||
| Last updated 14.21pm 06/05/2024 ? | |||||
| MSB (ASX) Chart |